Risk factors of postoperative pulmonary complications in patients with asthma and COPD

Takanori Numata, Katsutoshi NakayamaSatoko FujiiYoko YuminoNayuta SaitoMasahiro YoshidaYusuke KuritaKenji KobayashiSaburo ItoHirofumi UtsumiHaruhiko YanagisawaMitsuo HashimotoHiroshi WakuiShunsuke MinagawaTakeo IshikawaHiromichi HaraJun ArayaYumi Kaneko and Kazuyoshi Kuwano

Abstract

Background

Postoperative pulmonary complications (PPC) in patients with pulmonary diseases remain to be resolved clinical issue. However, most evidence regarding PPC has been established more than 10 years ago. Therefore, it is necessary to evaluate perioperative management using new inhalant drugs in patients with obstructive pulmonary diseases.

Methods

April 2014 through March 2015, 346 adult patients with pulmonary diseases (257 asthma, 89 chronic obstructive pulmonary disease (COPD)) underwent non-pulmonary surgery except cataract surgery in our university hospital. To analyze the risk factors for PPC, we retrospectively evaluated physiological backgrounds, surgical factors and perioperative specific treatment for asthma and COPD.

Results

Finally, 29 patients with pulmonary diseases (22 asthma, 7 COPD) had PPC. In patients with asthma, smoking index (≥ 20 pack-years), peripheral blood eosinophil count (≥ 200/mm3) and severity (Global INitiative for Asthma(GINA) STEP ≥ 3) were significantly associated with PPC in the multivariate logistic regression analysis [odds ratio (95% confidence interval) = 5.4(1.4–20.8), 0.31 (0.11–0.84) and 3.2 (1.04–9.9), respectively]. In patients with COPD, age, introducing treatment for COPD, upper abdominal surgery and operation time (≥ 5 h) were significantly associated with PPC [1.18 (1.00–1.40), 0.09 (0.01–0.81), 21.2 (1.3–349) and 9.5 (1.2–77.4), respectively].

Conclusions

History of smoking or severe asthma is a risk factor of PPC in patients with asthma, and age, upper abdominal surgery, or long operation time is a risk factor of PPC in patients with COPD. Adequate inhaled corticosteroids treatment in patients with eosinophilic asthma and introducing treatment for COPD in patients with COPD could reduce PPCs.

Download PDF

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: RSVP to the Back-to-School Twitter Party https://t.co/kfgS8pRncS, see more https://t.co/CpGiFuOOYd
7hreplyretweetfavorite
Interasma Top story: Three Common Comorbidities With Asthma https://t.co/UfB8hfM3H4, see more https://t.co/CpGiFuOOYd
10hreplyretweetfavorite
Interasma RT @ARIAGuideline: This article summarizes a EUFOREA symposium, presented during the European Rhinology Research Forum in Brussels (9-10 No…
16hreplyretweetfavorite
Interasma RT @ARIAGuideline: Rhinology future trends: 2017 EUFOREA debate on allergic rhinitis. https://t.co/ZMAchhHdBx
16hreplyretweetfavorite
Interasma RT @Aller_MD: Weekly Clinical Case Challenge from Derm101 https://t.co/TE5QVugg7W
16hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma